Target intelligence / Profile preview

Sulfatase-modifying factor 1 (SUMF1)

Target
SUMF1
Molecular classification
Enzyme, Post-translational modifier
01

Overview

Sulfatase-modifying factor 1 (SUMF1) is an essential enzyme responsible for a unique post-translational modification required for the catalytic activity of all sulfatases in humans. Located in the endoplasmic reticulum, SUMF1 (also known as formylglycine-generating enzyme, FGE) converts a conserved cysteine residue of the sulfatases into a C-alpha-formylglycine, the catalytic residue necessary for hydrolysis of sulfate esters. Deficiency or mutations in SUMF1 result in multiple sulfatase deficiency, a fatal lysosomal storage disorder characterized by neurologic, skeletal, and dermal abnormalities due to global impairment of all sulfatases. SUMF1 is regulated by protein-protein interactions, intracellular trafficking, and post-translational modifications. Beyond rare genetic disease, altered SUMF1 expression is also associated with cancer and inflammation, but there are no approved drugs directly targeting SUMF1.

Other names
Formylglycine-generating enzymeFGEC-alpha-formylglycine-generating enzyme 1FGly-generating enzymeUNQ3037AAPA3037
02

Mechanism of action

Enhancement of sulfatase activation (in the context of potential gene therapy co-delivery with sulfatase cDNA)

03

Biological functions

Activation of sulfatasesProtein post-translational modificationCellular sulfate metabolism
04

Disease associations

Lysosomal storage disorder (multiple sulfatase deficiency)Neurological diseaseSkeletal diseaseSkin diseaseCancer (possible roles in glioma and other tumors)Inflammatory and possibly neuroinflammatory diseases
05

Safety considerations

Loss-of-function leads to severe multisystem disease including neurodegeneration and organ dysfunction in multiple sulfatase deficiencyNo known safety concerns for inhibition in cancer, but roles in cell growth and immune status have been observed
06

Biomarkers

SUMF1 gene mutations in diagnosis of multiple sulfatase deficiency

Beyond the preview

Go deeper on Sulfatase-modifying factor 1 (SUMF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sulfatase-modifying factor 1 (SUMF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call